Cas no 5734-73-6 ((4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE)
(4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE Chemical and Physical Properties
Names and Identifiers
-
- (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE
- 4-chloro-N-cyclopropyl-6-methyl-2-Pyrimidinamine
- 4-chloro-N-cyclopropyl-6-methylpyrimidin-2-amine
- (4-Chloro-6-methylpyrimidin-2-yl)cyclopropylamine
- (6-chloro-4-methylpyrimidin-2-yl)cyclopropylamine
- AB1009998
- AK-51936
- AM100972
- KB-01773
- SBB075647
- 4-Chloro-2-(cyclopropylamino)-6-methylpyrimidine
- 4-chloro-N-cyclopropyl-6-methyl-pyrimidin-2-amine
- DTXSID20693796
- 5734-73-6
- AKOS015940321
- SB56291
- DB-353443
- CS-0366730
-
- MDL: MFCD18837189
- Inchi: 1S/C8H10ClN3/c1-5-4-7(9)12-8(10-5)11-6-2-3-6/h4,6H,2-3H2,1H3,(H,10,11,12)
- InChI Key: IIULORVJUVCTKK-UHFFFAOYSA-N
- SMILES: ClC1C=C(C)N=C(N=1)NC1CC1
Computed Properties
- Exact Mass: 183.0563250g/mol
- Monoisotopic Mass: 183.0563250g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 2
- Complexity: 160
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.4
- Topological Polar Surface Area: 37.8?2
Experimental Properties
- Density: 1.382
(4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM167816-1g |
4-Chloro-N-cyclopropyl-6-methylpyrimidin-2-amine |
5734-73-6 | 95% | 1g |
$583 | 2021-08-05 | |
| Fluorochem | 088417-500mg |
4-Chloro-6-methyl-pyrimidin-2-yl)-cyclopropyl-amine |
5734-73-6 | 95% | 500mg |
£293.00 | 2022-03-01 | |
| Fluorochem | 088417-1g |
4-Chloro-6-methyl-pyrimidin-2-yl)-cyclopropyl-amine |
5734-73-6 | 95% | 1g |
£503.00 | 2022-03-01 | |
| Chemenu | CM167816-1g |
4-Chloro-N-cyclopropyl-6-methylpyrimidin-2-amine |
5734-73-6 | 95% | 1g |
$624 | 2023-02-16 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1437400-1g |
4-Chloro-N-cyclopropyl-6-methylpyrimidin-2-amine |
5734-73-6 | 95+% | 1g |
¥4863.00 | 2024-05-08 | |
| A2B Chem LLC | AG77572-500mg |
4-Chloro-N-cyclopropyl-6-methylpyrimidin-2-amine |
5734-73-6 | 500mg |
$312.00 | 2024-04-19 | ||
| Ambeed | A625695-1g |
4-Chloro-N-cyclopropyl-6-methylpyrimidin-2-amine |
5734-73-6 | 95+% | 1g |
$560.0 | 2024-04-18 | |
| 1PlusChem | 1P00EJFO-500mg |
(4-Chloro-6-methyl-pyrimidin-2-yl)-cyclopropyl-amine |
5734-73-6 | 500mg |
$374.00 | 2025-02-27 | ||
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | J20_088417-500mg |
(4-Chloro-6-methyl-pyrimidin-2-yl)-cyclopropyl-amine |
5734-73-6 | 95% | 500mg |
¥6446.00 | 2025-04-14 | |
| SHANG HAI SHAO YUAN SHI JI Co., Ltd. | J20_088417-1g |
(4-Chloro-6-methyl-pyrimidin-2-yl)-cyclopropyl-amine |
5734-73-6 | 95% | 1g |
¥11066.00 | 2025-04-14 |
(4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE Related Literature
-
Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
-
Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
-
Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
Additional information on (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE
Comprehensive Overview of (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE (CAS No. 5734-73-6)
The compound (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE, with CAS No. 5734-73-6, is a specialized pyrimidine derivative that has garnered significant attention in pharmaceutical and agrochemical research. Its unique molecular structure, featuring a chloro-methyl pyrimidine core coupled with a cyclopropyl amine moiety, makes it a versatile intermediate for synthesizing bioactive molecules. Researchers are increasingly exploring its potential in drug discovery, particularly in the development of kinase inhibitors and antimicrobial agents.
In recent years, the demand for heterocyclic compounds like (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE has surged due to their role in addressing global challenges such as antibiotic resistance and chronic diseases. This compound's pyrimidine scaffold is a key building block in medicinal chemistry, often linked to targeted therapies for cancer and inflammatory conditions. Its CAS No. 5734-73-6 is frequently searched in academic databases, reflecting its relevance in cutting-edge research.
The synthesis of (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE involves multi-step organic reactions, including nucleophilic substitution and cyclopropanation. Its chloro and methyl functional groups enhance reactivity, enabling further derivatization for customized applications. Environmental and safety considerations are paramount during its production, aligning with the growing emphasis on green chemistry principles in industrial processes.
Analytical characterization of this compound typically employs advanced techniques such as NMR spectroscopy, mass spectrometry, and HPLC purity analysis. These methods ensure precise quality control, which is critical for its use in high-value applications. The compound's stability under various pH conditions and thermal profiles is also a subject of ongoing studies, particularly for formulation development.
From a commercial perspective, CAS No. 5734-73-6 is supplied by specialty chemical manufacturers catering to the pharmaceutical intermediates market. Its pricing and availability are influenced by factors like raw material costs and regulatory compliance. The compound's patent landscape and potential generic alternatives are closely monitored by industry stakeholders, reflecting its economic significance.
Future research directions for (4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE may explore its utility in bioconjugation techniques or as a ligand in catalytic systems. With the rise of AI-driven drug discovery, computational studies predicting its binding affinities could accelerate its adoption in next-generation therapeutics. This aligns with broader trends in precision medicine and sustainable chemical innovation.
5734-73-6 ((4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-CYCLOPROPYL-AMINE) Related Products
- 1420871-42-6(N1-(4-Chloro-6-methylpyrimidin-2-yl)cyclohexane-1,4-diamine hydrochloride)
- 1421035-35-9(4-Chloro-6-methyl-N-[(3S)-piperidin-3-yl]pyrimidin-2-amine;hydrochloride)
- 1289387-28-5(N1-(4-Chloro-6-methylpyrimidin-2-yl)cyclohexane-1,4-diamine hydrochloride)
- 54093-14-0(2-Pyrimidinamine, 4-chloro-N-cyclohexyl-6-methyl-)
- 5748-34-5((4-CHLORO-6-METHYL-PYRIMIDIN-2-YL)-ISOPROPYL-AMINE)
- 5734-70-3(2-Pyrimidinamine, 4-chloro-6-methyl-N-propyl-)
- 841260-80-8(2-Pyrimidinamine, 4-chloro-6-methyl-N-(2-methylpropyl)-)
- 841260-78-4(2-Pyrimidinamine, 4-chloro-N-hexyl-6-methyl-)
- 5748-33-4(4-Chloro-N-ethyl-6-methylpyrimidin-2-amine)
- 838902-88-8(2-Pyrimidinamine, 4-chloro-6-methyl-N-octyl-)